Nordic NECT has been a cooperation cooperation between phase I units in Denmark, Finland, Norway and Sweden, performing early clinical trials in oncology.

The network was designed to promote patient access to new investigational drugs and access to phase I and early phase II programs in the Nordic countries.  More about us.

Nordic NECT came to an end in October 2024, and the continued Nordic collaboration will be in the newly established Nordic Tumor Board (NTB).

This webpage will be closed in spring 2025.

Oncotrialfinder.com is a free of charge search engine developed by Novartis in collaboration with NordicNect and Convert Group AS